Study, country and study design | Inclusion criteria for patients | Number of patients (I/C)*; average age of patients (I/C)*; number of physicians (I/C*) | Intervention and control group* | Data collection periods | Number of adverse events (e.g. hospitalisations, deaths) or side effects |
---|---|---|---|---|---|
Bjerrum et al. 2006 Spain Two-armed cluster-randomised controlled intervention study | > 14 years Consultation due to upper/lower RTI | T0: 1114/not performed; n.r. T1: 1674/2462; n.r. Physicians on T0: 52 Physicians on T1: 17/35 | IG: training for physicians + feedback and reflection of baseline—Abx prescription rate + introduction to POCT (CRP and RADT) CG: care as usual | Abx prescription rate right after initial consultation: T0: only for IG (Dec.–Feb. 02/03) T1: 1 year after I (Dec.–Feb. 04/05) | n.r. |
Altiner et al. 2007 Germany Two-armed cluster-randomised controlled intervention study | > 16 years First episode of acute cough (no cough for the previous 8 weeks) | T0: 753/898; 42.2/42 T1: 675/885; 44.9/43.9 T2: 787/920; 41.7/41.8 Physicians on T0: 104 Physicians on T1: 42/44 Physicians on T2: 28/33 | IG: communication training for physicians + handouts for patients and waiting room poster CG: care as usual | Abx prescription rate right after initial consultation: T0: Nov.–Jan. 03/04 T1: 6 weeks after I (Feb.–Apr. 2004) T2: 1 year after I (Jan.–Mar. 2005) | n.r. |
Gonzales et al. 2013 USA Three-armed cluster-randomised controlled intervention study | 13–64 years Consultation due to uncomplicated acute bronchitis (ICD-9-CM code 466.0; ICD-9-CM code 490) (No RTI consultation in the last 30 days) | T0: Arm 1: 3639; n.r. Arm 2: 2974; n.r. Arm 3: 3195; n.r. T1: Arm 1: 1001; n.r. Arm 2: 1017; n.r. Arm 3: 950; n.r. 11 “practice centres” for each study arm Arm 1: 68 physicians Arm 2: 41 physicians Arm 3: 46 physicians | IG 1: 1) Training for physicians (via “clinical champion”) 2) Patient brochure 3) Examination room poster with clinical algorithm for acute bronchitis IG 2: 1) and 2) instead of 3) ➔ clinical algorithm integrated in practice software CG: care as usual | Abx prescription rate right after initial consultation: T0: baseline (3 successive winter periods from Oct. to Mar. 2007–2009) T1: Oct. 2009–Mar. 2010 | Hospitalisations and emergency room visits occurred rarely in all study arms (no published data) |
Gjelstad et al. 2013** Norway Two-armed cluster-randomised controlled intervention study | > 13 years Consultation due to acute RTI | Number of RTI consultations on T0 for patients > 13 years: 43880/46518 Number of RTI-consultations on T1 for patients > 13 years: 47522/47868 Number of physicians on T0: 39 education groups (202 physicians); n.r./41 education groups (232 physicians); n.r. Number of physicians on T1: 39 education groups (183 physicians); 48.3/40 education groups (199 physicians); 49.7 | IG 1: 1) Meeting: guidelines for RTI and strategy of delayed prescribing; installation of additional program for 2 of 4 practice software (reminders to document the number of days for delayed prescribing) 2) Meeting: feedback on prescribing rates based on individual data 3) 1-day seminar: reinforcement of intervention IG 2: Training regarding adequate pharmacotherapy on patients > 70 years in 2 group meetings and 1-day peer visit, based on individual prescribing rates; antibiotic therapy was not content | 2 data collection periods for Abx prescription rate: T0: (Abx prescription rate during 1 year before I by retrospective data analysis with special software) I: Dec. 2005–May 2006 T1: Abx prescription rate during 1 year (after I) | n.r. |
Little et al. 2013 Belgium, Spain, Wales, Great Britain, Poland, Netherlands Multinational cluster-randomised controlled intervention study, factorial study design | > 18 years First episode of acute cough (max. of 28 days) First episode of upper/lower RTI | T0: 6771; 49.6 T1: 4264 Arm 1 = CG: 870 Arm 2 = IG 1: 1062 Arm 3 = IG 2: 1170 Arm 4 = IG 3: 1162 Factorial groups: POCT-CRP-group (arms 2 + 4): 2224; 51.0 CG for CRP-POCT = no CRP-POCT group (arms 1 + 3): 2040; 50.9 CST-group (arms 3 + 4): 2332; 51.1 CG for CST = no CST group (arms 1 + 2): 1932; 50.8 Physicians on T0: 259 practices Physicians on T1: 228 practices; 372 physicians | CG: care as usual IG 1: Internet-based training for CRP-POCT IG 2: Internet-based communication training IG 3: Internet-based training for communication training + CRP-POCT | Abx prescription rate right after initial consultation: T0: Oct.–Dec. 2010 T1: Feb.–May 2011 | Deaths: none Hospitalisations: CG: 2 IG 1: 10 IG 2: 6 IG 3: 12 Difference in hospitalisation rate between cumulative CRP group and cumulative non-CRP group: 22/8 (OR* = 2.91, 95% CI 0.96–8.85, p = 0.06) Cluster-adjusted: OR* = 2·61, 95% CI 1.07–6.35, p = 0.034 |
Andreeva et al. 2014 Russia Two-armed cluster-randomised controlled intervention study | Patients ≥ 18 years with first episode of acute cough/lower RTI (including acute bronchitis, pneumonia and infectious exacerbations of COPD or asthma) | T0 for subgroup of 13 GPs: 47/34; n.r. T1 for subgroup of 13 GPs: 81/62; n.r. T1: 101/78; 50.8/50.8 Physicians: a total of 18 GPs participated, but only 13 GPs participated in baseline and intervention period | IG: 1) Registration of patient’s symptoms, clinical examination and therapy in electronic case report form 2) 2 training sessions concerning the CRP test, guidelines about the interpretation of CRP results, discussion about paper cases of patients with different RTIs and different CRP values CG: 1) | Abx prescription rate during I period (12 weeks—from 30 January to 30 April 2010) T0: only for 13 GPs 2 months before data collection T1: Abx prescription rate right after initial consultation T2: Abx prescription rate 2 weeks after initial consultation | n.r. |
Gulliford et al. 2014 UK Two-armed cluster-randomised controlled intervention study | Patients aged 18–59 years consulting for RTI | T0: 292,398/264,137; n.r. T1: 294,929/263,895; n.r. 50 family practices were allocated to IG, and 50 practices were allocated to CG | IG: decision support tool including a summary of antibiotic prescribing recommendations and research evidence concerning no antibiotic or delayed antibiotic prescribing strategies + a single-sided patient information sheet, information on the definite indications for antibiotic prescription CG: care as usual | Abx prescription rate during two 12-month data collection periods: T0: 12-month period before I T1: 12-month period after I | n.r. |
Meeker et al. 2016 USA Cluster-randomised controlled intervention study, 2 × 2 × 2 factorial design | Patients ≥ 18 years with no visit for acute RTI within the prior 30 days | No. of patients: 14,753/16,959 No. of patients T0/T1 for each study group: IG 1: 2132/2388 IG 2: 1491/1979 IG 3: 1236/1620 IG 1 + 2: 1977/2131 IG 1 + 3: 1511/2014 IG 2 + 3: 2362/2240 IG 1 + 2 + 3: 2178/2492 CG: 1866/2095 No. of practices/physicians for T0 and T1: 47/248 No. of practices/physicians/mean age of patients for each study group: IG 1: 6/42/48 IG 2: 7/35/53 IG 3: 4/20/47 IG 1 + 2: 6/34/50 IG 1 + 3: 6/35/48 IG 2 + 3: 6/27/49 IG 1 + 2 + 3: 6/28/43 CG: 6/27/49 | 7 IGs: I1: “Suggested alternatives”—EHR-based intervention (resembling CDSS) triggered by a RTI. User gets a list of alternative treatment (e.g. over-the-counter medicine) I2: “Accountable justification”—EHR-based I triggered by antibiotic prescriptions. User must explicitly justify the treatment decision. I3: “Peer comparison”—monthly e-mail with individual number and proportion of adequate and inadequate antibiotic prescriptions for acute RTI compared with other physicians I4: I1 + I2 I5: I1 + I3 I6: I2 + I3 I7: I1 + I2 + I3 CG: care as usual | Abx prescription rate for inadequate antibiotic prescriptions for acute RTI T0: 18-month baseline for each practice T1: 18-month period (beginning Nov. 2011 to Oct. 2012, ending for the last practice in Apr. 2014) | Return visit rate within 30 days after initial consultation in which no antibiotics were prescribed: Among CG practices: 0.43% (95% CI 0.25–0.70) Among I2 and I3 practices: 1.41% (95% CI 1.06–1.85, p < 0.001) Among return visits, a random sample of 33 cases across all study groups was monitored for complications/hospitalizations: 11 cases of pneumonia, 1 otitis media, 1 pneumonia + otitis media 1 hospitalisation for pneumonia |